- Drugs
- Wednesday, 18 Dec 2019
Medical Marijuana, Inc. Appoints New Chief Financial Officer
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has promoted its VP of Corporate Finance Brooke Beers to Chief Financial Officer of the Company.
"Brooke's contributions to the Company have been extraordinary," said Medical Marijuana, Inc. COO Blake Schroeder. "He's helped us overcome several financial obstacles that many cannabis companies face every day and he has helped us significantly improve our public reporting practices to increase transparency."
Beers was hired by Medical Marijuana, Inc. in 2017 and has since been leading the Company's accounting department, handling the Company's budget management, public financial reports, e-commerce offerings, and forecasting needs.
"Working with the Medical Marijuana, Inc. team has been an incredibly rewarding experience," said Beers. "Last December, the Brightfield Group reported that our Company represents 10 percent of the entire CBD market and I'm proud to be a part of that financial milestone and many more to come. It's encouraging to work with a large group of highly motivated professionals and claim our stake in the global CBD industry."
Related Industry Updates
Nasal Polyps Treatment Market Size will Escalate Rapidly in the Near Future 2020: Forecast 2027 by OptiNose US, Inc. , Regeneron Pharmaceuticals, Inc. , Merck KGaA , Pfizer, Inc.
Apr 09, 2021
Amid bitter trade war, U.S. companies pledge millions of dollars in aid
Feb 07, 2020
Mediterranean Fish Vaccine Market is expected to reach US$ 2,09,030.80 million by 2030
Aug 10, 2023
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Sep 17, 2019
GSK sells $3.35 billion stake in Unilever’s Indian business
May 07, 2020
Global Recall of the Common Heartburning Drugs Over the Risk of Cancer
Jan 21, 2020
Transdermal Medical Patch Market is expected to reach US$ 10,799.74 million by 2028
Jun 06, 2023